Tumor Biology

, Volume 36, Issue 3, pp 2155–2161 | Cite as

DNA repair gene polymorphisms in B cell non-Hodgkin’s lymphoma

  • Aykut Bahceci
  • Semra Paydas
  • Kahraman Tanriverdi
  • Melek Ergin
  • Gulsah Seydaoglu
  • Gulsum Ucar
Research Article


Cancer is a group of diseases characterized by DNA injury, and genetic and environmental factors are important in the etiology of the cancers. It is well known that there are association variabilities in DNA repairment and sensitivity against the cancer. The aim of this study is to look for some important gene polymorphisms associated with DNA repair in cases with B cell non-Hodgkin’s lymphoma (B-NHL). Ninety-four cases with NHL and 96 healthy controls were included in this study. ERCC2 (Lys751Gln), XPC (Gln939Lys), ERCC5 (Asp1104His), and XRCC3 (Thr241Met) gene polymorphisms were studied by using Tm Shift Real-Time PCR Technology. ERCC5 Asp1104His polymorphism showed a protective effect against the B-NHL in individuals carrying this mutant allele (p = 0.009), and differences were more prominent in males (p = 0.001). When the patient and control groups were divided according to their smoking habit, the mutant allele of the XPC gene showed a protective effect in the nonsmoker group (p = 0.040). The mutant allele G of ERCC5 (CG) polymorphism was found to be protective against lymphoma (p = 0.010). There were no differences among cases with B-NHL and controls for ERCC2 codon 751, XPC codon 939, and XRCC3 codon 241 gene polymorphisms. DNA repair gene polymorphisms can affect the risk of lymphoma, and it will be useful to detect the DNA repair gene polymorphisms in cases with lymphoma in studies covering a higher number of cases.


Capacity of DNA repairment Gene polymorphism Risk Lymphoma Age 



This study has been supported by the Turkish Medical Oncology Society and Cukurova University Research Fund.

Conflicts of interest



  1. 1.
    Hu JJ, Mohrenweiser HW, Bell DA, Leadon SA, Miller MS. Symposium overview: genetic polymorphism in DNA repair and cancer risk. Toxicol Appl Pharmacol. 2002;185:64–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol. 2006;24:541–70. Review.CrossRefPubMedGoogle Scholar
  3. 3.
    Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino asid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensivity. Carcinogenesis. 2001;22:917–22.CrossRefPubMedGoogle Scholar
  4. 4.
    Kumar R, Angelini S, Hemminki K. Simultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphism. Mutagenesis. 2003;18:207–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NGJ, et al. Xeroderma pigmentosum and trichotthiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transkription gene. Proc Natl Acad Sci. 1997;94:8658–63.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Taylor EM, Lehmann AR. Conservation of eukaryotic DNA repair mechanisms. Int J Radiat Biol. 1998;74(3):277–86.CrossRefPubMedGoogle Scholar
  7. 7.
    Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature. 2001;411(6835):366–74.CrossRefPubMedGoogle Scholar
  8. 8.
    Tornaletti S, Hanawalt PC. Effect of DNA lesions on transcription elongation. Biochimie. 1999;81:139–46.CrossRefPubMedGoogle Scholar
  9. 9.
    Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene. 2002;21:8949–56.CrossRefPubMedGoogle Scholar
  10. 10.
    Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10(2):125–31.PubMedGoogle Scholar
  11. 11.
    Lamerdin JE, Montgomery MA, Stilwagen SA, Scheidecker LK, Tebbs RS, Brookman KW, et al. Genomik sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics. 1995;25:547–54.CrossRefPubMedGoogle Scholar
  12. 12.
    Xu Z, Hua LX, Qian LX, Yang J, Wang XR, Zhanq W, et al. Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China. Asian J Androl. 2007;9:331–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphism: effects on aflatoxin B1- DNA adducts and glycophorin A variant frequency. Cancer Res. 1999;59:2557–61.PubMedGoogle Scholar
  14. 14.
    Huang J, Ye F, Chen H, Lu W, Xie X. The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. Int J Gynecol Cancer. 2007;17:668–75.CrossRefPubMedGoogle Scholar
  15. 15.
    Wang J, Chuang K, Ahluwalia M, Patel S, Umblas N, Mirel D, et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. BioTechniques. 2005;39:885–93.CrossRefPubMedGoogle Scholar
  16. 16.
    Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2(12):920–32.CrossRefPubMedGoogle Scholar
  17. 17.
    Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res. 2002;8:802–10.PubMedGoogle Scholar
  18. 18.
    de Miranda NF, Peng R, Georgiou K, Wu C, Falk Sörqvist E, Berglund M, et al. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med. 2013;210(9):1729–42. doi: 10.1084/jem.20122842.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Li J, Stern DF. Regulation of CHK2 by DNA-dependent protein kinase. J Biol Chem. 2005;280(12):12041–50.CrossRefPubMedGoogle Scholar
  20. 20.
    Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, Vajdic CM, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica. 2007;92:1180–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schöllkopf C, Chang ET, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev. 2006;15:258–65.CrossRefPubMedGoogle Scholar
  22. 22.
    Matsuo K, Hamajima N, Suzuki R, Andoh M, Nakamura S, Seto M, et al. Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan. Cancer Genet Cytogenet. 2004;149:77–80.CrossRefPubMedGoogle Scholar
  23. 23.
    Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet. 2006;119:659–68.CrossRefPubMedGoogle Scholar
  24. 24.
    Joseph T, Kusumakumary P, Chacko P, Abraham A, Pillai MR. DNA repair gene XRCC1 polymorphisms in childhood acute lymphoblastic leukemia. Cancer Lett. 2005;217:17–24.CrossRefPubMedGoogle Scholar
  25. 25.
    Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;48:16–20.CrossRefPubMedGoogle Scholar
  26. 26.
    Batar B, Güven M, Baris S, Celkan T, Yildiz I. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leuk Res. 2009;33:759–63.CrossRefPubMedGoogle Scholar
  27. 27.
    Tumer TB, Yılmaz D, Tanrikut C, Sahin G, Ulusoy G, Arinc E. DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res. 2010;34:1275–81.CrossRefPubMedGoogle Scholar
  28. 28.
    Kim IS, Kim DC, Kim HG, Eom HS, Kong SY, Shin HJ, et al. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population. Cancer Genet Cytogenet. 2010;196:31–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Hill DA, Wang SS, Cerhan JR, Davis S, Cozen W, Severson RK, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood. 2006;108:3161–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Liu J, Song B, Wang Z, Song X, Shi Y, Zheng J, et al. DNA repair gene XRCC1 polymorphisms and non-Hodgkin lymphoma risk in a Chinese population. Cancer Genet Cytogenet. 2009;191:67–72.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Aykut Bahceci
    • 1
  • Semra Paydas
    • 1
  • Kahraman Tanriverdi
    • 2
  • Melek Ergin
    • 3
  • Gulsah Seydaoglu
    • 4
  • Gulsum Ucar
    • 5
  1. 1.Department of Medical OncologyUniversity of CukurovaAdanaTurkey
  2. 2.University of Massachusetts Medical SchoolWorcesterUSA
  3. 3.Department of PathologyUniversity of CukurovaAdanaTurkey
  4. 4.Department of BiostatisticsUniversity of CukurovaAdanaTurkey
  5. 5.Department of Pediatric HematologyUniversity of CukurovaAdanaTurkey

Personalised recommendations